235 related articles for article (PubMed ID: 12560920)
1. Clinical utility of grading criteria for submucosal invasion in the prognosis of T1 colorectal carcinomas.
Masaki T; Sugiyama M; Matsuoka H; Abe N; Izumisato Y; Goto A; Sakamoto A; Atomi Y
J Gastroenterol; 2003; 38(1):37-44. PubMed ID: 12560920
[TBL] [Abstract][Full Text] [Related]
2. Possible contribution of CD44 variant 6 and nuclear beta-catenin expression to the formation of budding tumor cells in patients with T1 colorectal carcinoma.
Masaki T; Goto A; Sugiyama M; Matsuoka H; Abe N; Sakamoto A; Atomi Y
Cancer; 2001 Nov; 92(10):2539-46. PubMed ID: 11745187
[TBL] [Abstract][Full Text] [Related]
3. Relation of E-cadherin and beta-catenin expression to pit pattern in colorectal cancer.
Kojima M; Shiokawa A; Ohike N; Tamegai Y; Kato H; Morohoshi T
Oncol Rep; 2004 Sep; 12(3):533-8. PubMed ID: 15289833
[TBL] [Abstract][Full Text] [Related]
4. Laminin-5 gamma 2 chain and matrix metalloproteinase-2 may trigger colorectal carcinoma invasiveness through formation of budding tumor cells.
Masaki T; Matsuoka H; Sugiyama M; Abe N; Izumisato Y; Goto A; Sakamoto A; Atomi Y
Anticancer Res; 2003; 23(5b):4113-9. PubMed ID: 14666611
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of tumor cell dissociation as a predictive marker of lymph node metastasis in submucosal invasive colorectal carcinoma.
Hori H; Fujimori T; Fujii S; Ichikawa K; Ohkura Y; Tomita S; Ono Y; Imura J; Kuroda Y
Dis Colon Rectum; 2005 May; 48(5):938-45. PubMed ID: 15785891
[TBL] [Abstract][Full Text] [Related]
6. Matrilysin (MMP-7) as a significant determinant of malignant potential of early invasive colorectal carcinomas.
Masaki T; Matsuoka H; Sugiyama M; Abe N; Goto A; Sakamoto A; Atomi Y
Br J Cancer; 2001 May; 84(10):1317-21. PubMed ID: 11355941
[TBL] [Abstract][Full Text] [Related]
7. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids.
Pelosi G; Scarpa A; Puppa G; Veronesi G; Spaggiari L; Pasini F; Maisonneuve P; Iannucci A; Arrigoni G; Viale G
Cancer; 2005 Mar; 103(6):1154-64. PubMed ID: 15712207
[TBL] [Abstract][Full Text] [Related]
8. Tumor budding is predictive of lymphatic involvement and lymph node metastases in submucosal invasive colorectal adenocarcinomas and in non-polypoid compared with polypoid growths.
Ogawa T; Yoshida T; Tsuruta T; Tokuyama W; Adachi S; Kikuchi M; Mikami T; Saigenji K; Okayasu I
Scand J Gastroenterol; 2009; 44(5):605-14. PubMed ID: 19221929
[TBL] [Abstract][Full Text] [Related]
9. A multivariate analysis of adhesion molecules expression in assessment of colorectal cancer.
Ngan CY; Yamamoto H; Seshimo I; Ezumi K; Terayama M; Hemmi H; Takemasa I; Ikeda M; Sekimoto M; Monden M
J Surg Oncol; 2007 Jun; 95(8):652-62. PubMed ID: 17443723
[TBL] [Abstract][Full Text] [Related]
10. Actual number of tumor budding as a new tool for the individualization of treatment of T1 colorectal carcinomas.
Masaki T; Matsuoka H; Sugiyama M; Abe N; Sakamoto A; Atomi Y
J Gastroenterol Hepatol; 2006 Jul; 21(7):1115-21. PubMed ID: 16824062
[TBL] [Abstract][Full Text] [Related]
11. Expression of E-cadherin, alpha-catenin, beta-catenin, and CD44 (standard and variant isoforms) in human cholangiocarcinoma: an immunohistochemical study.
Ashida K; Terada T; Kitamura Y; Kaibara N
Hepatology; 1998 Apr; 27(4):974-82. PubMed ID: 9537436
[TBL] [Abstract][Full Text] [Related]
12. The risk of lymph node metastasis in T1 colorectal carcinoma.
Yamamoto S; Watanabe M; Hasegawa H; Baba H; Yoshinare K; Shiraishi J; Kitajima M
Hepatogastroenterology; 2004; 51(58):998-1000. PubMed ID: 15239233
[TBL] [Abstract][Full Text] [Related]
13. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis.
Joo M; Lee HK; Kang YK
Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426
[TBL] [Abstract][Full Text] [Related]
14. Abnormal expression of E-cadherin and beta-catenin may be a molecular marker of submucosal invasion and lymph node metastasis in early gastric cancer.
Tanaka M; Kitajima Y; Edakuni G; Sato S; Miyazaki K
Br J Surg; 2002 Feb; 89(2):236-44. PubMed ID: 11856141
[TBL] [Abstract][Full Text] [Related]
15. Metastatic potential in T1 and T2 colorectal cancer.
Fang WL; Chang SC; Lin JK; Wang HS; Yang SH; Jiang JK; Chen WC; Lin TC
Hepatogastroenterology; 2005; 52(66):1688-91. PubMed ID: 16334758
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for occult lymph node metastasis of colorectal cancer invading the submucosa and indications for endoscopic mucosal resection.
Yasuda K; Inomata M; Shiromizu A; Shiraishi N; Higashi H; Kitano S
Dis Colon Rectum; 2007 Sep; 50(9):1370-6. PubMed ID: 17661146
[TBL] [Abstract][Full Text] [Related]
17. Correlations between lymph node metastasis and depth of submucosal invasion in submucosal invasive colorectal carcinoma: a Japanese collaborative study.
Kitajima K; Fujimori T; Fujii S; Takeda J; Ohkura Y; Kawamata H; Kumamoto T; Ishiguro S; Kato Y; Shimoda T; Iwashita A; Ajioka Y; Watanabe H; Watanabe T; Muto T; Nagasako K
J Gastroenterol; 2004 Jun; 39(6):534-43. PubMed ID: 15235870
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of CD44 expression in colorectal carcinomas.
Sökmen S; Lebe B; Sarioglu S; Füzün M; Terzi C; Küpelioglu A; Ellidokuz H
Anticancer Res; 2001; 21(6A):4121-6. PubMed ID: 11911305
[TBL] [Abstract][Full Text] [Related]
19. Indications for subsequent surgery after endoscopic resection of submucosally invasive colorectal carcinomas: a prospective cohort study.
Choi DH; Sohn DK; Chang HJ; Lim SB; Choi HS; Jeong SY
Dis Colon Rectum; 2009 Mar; 52(3):438-45. PubMed ID: 19333043
[TBL] [Abstract][Full Text] [Related]
20. Mixed-histologic-type submucosal invasive gastric cancer as a risk factor for lymph node metastasis: feasibility of endoscopic submucosal dissection.
Hanaoka N; Tanabe S; Mikami T; Okayasu I; Saigenji K
Endoscopy; 2009 May; 41(5):427-32. PubMed ID: 19418397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
